Amarin Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly and | Outperform |
16
|
$777.77 | $636.99 | 13.14% | 9 | $690.32B |
| JNJ | Johnson & Johnson | Outperform |
9
|
$148.72 | $174.55 | 14.31% | 3 | $357.58B |
| AZN | AstraZeneca PLC | Outperform |
17
|
£121.18 | £165.99 | 34.47% | 16 | £186.80B |
| AMGN | Amgen | Outperform |
4
|
$300.30 | $303.65 | 6.56% | 8 | $160.65B |
| PFE | Pfizer | Outperform |
2
|
$27.77 | $32.87 | 9.83% | 6 | $159.46B |
| SAN | Sanofi | Outperform |
16
|
91.88€ | 102.80€ | 18.63% | 9 | 113.65€B |
| BMY | Bristol-Myers Squibb | Hold |
2
|
$44.04 | $58.15 | 22.62% | 10 | $88.99B |
| GILD | Gilead Sciences Inc | Outperform |
11
|
$65.46 | $87.82 | 22.21% | 14 | $81.73B |
| BAYN | Bayer | Hold |
5
|
28.49€ | 45.15€ | 5.30% | 4 | 27.57€B |
| MTNB | Matinas BioPharma Holdings | Buy |
7
|
$0.17 | $0.65 | 488.24% | 0 | $56.27M |
| CDXI | Cardax | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.00M |